Biomarin Pharmaceutical (BM8.MU) Q3 2026 Earnings

4AugConfirmed
Q2 2026
Next
0.59
0.67
0.75
0.83

Details

Expected EPS
0.8300403373
Actual EPS
N/A
Surprise EPS
-0.83
Surprise Percent
+100%

Description

Biomarin Pharmaceutical (BM8.MU) will report earnings of for Q3 2026 on August 04, 2026.

0 Comments

Share your thoughts